Enjoy complimentary customisation on priority with our Enterprise License!
Technavio’s market research analyst predicts the global neurosurgery market to grow at a CAGR of more than 9% during the forecast period. The rising instances of neurosurgical disorders such as subarachnoid hemorrhage, meningitis, intracerebral hemorrhage (ICH), and traumatic brain injury (TBI) are boosting the adoption of neurosurgery devices. The introduction of flow diversion devices, stents, liquid embolic, and clot retrieval devices is replacing conventional treatment alternatives such as pharmacological therapy and surgical clipping. At present, surgeons are using neuroendovascular coils and other non-coil devices, which offers long-term treatment compared with drug therapies. Such developments have prompted vendors to focus on getting adequate clinical data and findings on safety and efficacy of coils, flow diversion devices, neurostimulation devices, and advanced surgical navigation systems, which will subsequently increase the implementation rates in the coming years. The growing recognition and implementation of such new devices with superior features will enhance the growth prospects for the neurosurgery market in the coming years.
Several vendors in the market are focusing on integrating neuroprosthetic technologies with electrical neuromodulation and pharmacological therapies for the brain, brainstem, and spinal cord. The pharmacological components used in this hybrid neuroprosthetic device include a catheter implanted in the brain tissue and a subcutaneously placed drug reservoir, which can be regularly refilled. This combination of two technologies can result in the efficient and effective treatment of the diseases. The growing adoption of neurostimulation devices for the treatment of neurological disorders, especially among the older population, is expected to fuel the growth of the market.
The growing awareness about the neurology devices among people with several successful procedures has prompted individuals to undergo neurosurgeries. Advancements in technology and new product launches have intensified the competitive scenario in the market. Vendors are collaborating to form strategic alliances with specialized companies manufacturing neurosurgical devices to extend their product portfolio and widen their customer base. Also, manufacturers are developing support devices to minimize the complications of flow diversions.
Leading vendors in the market are -
Other prominent vendors in the neurosurgery market include Abbott Laboratories, ABIOMED, Acandis, AdvanSource Biomaterials, Allium Medical, AngioDynamics, Angioslide, Atrium Medical, B. Braun Melsungen, Balt Extrusion, Biophan Technologies, Biosense Webster, BIOTRONIK, Boston Scientific, Brainlab, Cardiac Science, CardiacAssist (TandemLife), Cardica, Claret Medical, Contego Medical, Cook Group, CryoLife, Cyberonics, Elekta, Gore Medical, Innovative Cardiovascular Solutions, InspireMD, KARL STORZ, Keystone Heart, Micromar, MicroVention, Neuros Medical, NeuroVista, Nobilis Health, PHENOX, Scopis, SPR Therapeutics, St. Jude Medical, Synapse Biomedical, Terumo, and Transverse Medical.
Neurostimulation devices occupy the largest portion of the market and will continue its dominance throughout the forecast period. The segment includes implantable devices that deliver electrical stimulation to the brain and nervous system to cure neurological disorders such as pain, PD, epilepsy, depression, dystonia, obsessive-compulsive disorder, and tremors. Neurostimulation devices, such as SCS, DBS, SNS, VNS, and GES, are powered by batteries that are replaced every 3-5 years. Vendors are investing in the development of new devices and research for the application of innovative products for other disease treatments. For instance, Cyberonics applied for CE mark approval of the VNS system to treat chronic heart failure.
The Americas was the largest revenue contributor to the global neurosurgery market and accounted for the highest market shares in 2015. The region is witnessing rising incidences of cerebral disorders such as stenosis, malformation, and brain aneurysm, which are fuelling growth prospects for the market in the Americas. The adoption rate of neurosurgery is also very high in the region due to the prevalence of MI procedures. Technological developments coupled with the rising incidences of cerebral aneurysm are anticipated to drive the market over the forecast period.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by application
PART 07: Global neurostimulation devices market
PART 08: Global neurointerventional devices market
PART 09: Global CSF management devices
PART 10: Global neurosurgical navigation system
PART 11: Market segmentation by end-user
PART 12: Geographical segmentation
PART 13: Buying criteria
PART 14: Market drivers
PART 15: Impact of drivers
PART 16: Market challenges
PART 17: Impact of drivers and challenges
PART 18: Market trends
PART 19: Vendor landscape
PART 20: Key vendor analysis
PART 21: Appendix
PART 22: Explore Technavio
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.